Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Jan 2022 for Ampio Pharmaceuticals, Inc., €12k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dan Stokely: trading record in brief
This profile gathers the share dealings of Dan Stokely in Ampio Pharmaceuticals, Inc., where the filings describe the role as finance chief. Between 17 May 2021 and 1 January 2022, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 4 January 2022, reports a share grant of €12k in Ampio Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dan Stokely
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
22,914 shares@ US$0.5716.1% of flowCommon StockSEC:0001415889-22-000260:0
28,127 shares@ US$1.6455.4% of flowCommon StockSEC:0001415889-21-005020:0
335,000 shares0Common StockSEC:0001415889-21-004869:0
22,500 shares@ US$0.4311.3% of flowCommon StockSEC:0001415889-21-003253:0
35,000 shares@ US$0.4317.2% of flowCommon StockSEC:0001415889-21-002569:0
5 of 5 declarations
